APO Research, Inc.

APO RESEARCH · REPORT

Personal Dosimetry Service

Selected research

Market Analysis & Forecast

Global Personal Dosimetry Service Market Analysis and Forecast 2026-2032

Market perspective

The global Personal Dosimetry Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Personal Dosimetry Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Personal Dosimetry Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Personal Dosimetry Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Personal Dosimetry Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Personal Dosimetry Service include Landauer, Chiyoda Technol Corporation, Kinetics, Mirion, RadPro, Sanova, TÜV Rheinland, SCI and Centro de Dosimetría, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Personal Dosimetry Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Personal Dosimetry Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Personal Dosimetry Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Personal Dosimetry Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Personal Dosimetry Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Personal Dosimetry Service revenue, projected growth trends, production technology, application and end-user industry.

Personal Dosimetry Service Segment by Company

Landauer

Chiyoda Technol Corporation

Kinetics

Mirion

RadPro

Sanova

TÜV Rheinland

SCI

Centro de Dosimetría

ARPANSA

Sierra Radiation

IRS

Dental Directory

Personal Dosimetry Service Segment by Type

Badge Dosimetry

Thermoluminescent Dosimetry (TLD)

Optically Stimulated Luminescence (OSL)

Electronic Dosimeters

Others

Personal Dosimetry Service Segment by Application

Medical

Industrial

Research

Nuclear Facilities

Others

Personal Dosimetry Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personal Dosimetry Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personal Dosimetry Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personal Dosimetry Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Personal Dosimetry Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Personal Dosimetry Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personal Dosimetry Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Personal Dosimetry Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Badge Dosimetry Major Player Table 3. Thermoluminescent Dosimetry (TLD) Major Player Table 4. Optically Stimulated Luminescence (OSL) Major Player Table 5. Electronic Dosimeters Major Player Table 6. Others Major Player Table 7. Global Personal Dosimetry Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Medical Major Player Table 9. Industrial Major Player Table 10. Research Major Player Table 11. Nuclear Facilities Major Player Table 12. Others Major Player Table 13. Personal Dosimetry Service Industry Trends Table 14. Personal Dosimetry Service Industry Drivers Table 15. Personal Dosimetry Service Industry Opportunities and Challenges Table 16. Personal Dosimetry Service Industry Restraints Table 17. Global Personal Dosimetry Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Personal Dosimetry Service Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Personal Dosimetry Service Market Share by Region (2021-2026) Table 20. Global Personal Dosimetry Service Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Personal Dosimetry Service Market Share by Region (2027-2032) Table 22. Global Personal Dosimetry Service Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Personal Dosimetry Service Revenue Market Share by Players (2021-2026) Table 24. Global Personal Dosimetry Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Personal Dosimetry Service Key Players Headquarters & Area Served Table 26. Global Personal Dosimetry Service Players, Product Type & Application Table 27. Global Personal Dosimetry Service Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Personal Dosimetry Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Personal Dosimetry Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Personal Dosimetry Service Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Personal Dosimetry Service Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Personal Dosimetry Service Revenue Market Share by Type (2021-2026) Table 34. Global Personal Dosimetry Service Revenue Market Share by Type (2027-2032) Table 35. Global Personal Dosimetry Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Personal Dosimetry Service Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Personal Dosimetry Service Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Personal Dosimetry Service Revenue Market Share by Application (2021-2026) Table 39. Global Personal Dosimetry Service Revenue Market Share by Application (2027-2032) Table 40. Landauer Company Information Table 41. Landauer Business Overview Table 42. Landauer Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Landauer Personal Dosimetry Service Product Portfolio Table 44. Landauer Recent Development Table 45. Chiyoda Technol Corporation Company Information Table 46. Chiyoda Technol Corporation Business Overview Table 47. Chiyoda Technol Corporation Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Chiyoda Technol Corporation Personal Dosimetry Service Product Portfolio Table 49. Chiyoda Technol Corporation Recent Development Table 50. Kinetics Company Information Table 51. Kinetics Business Overview Table 52. Kinetics Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Kinetics Personal Dosimetry Service Product Portfolio Table 54. Kinetics Recent Development Table 55. Mirion Company Information Table 56. Mirion Business Overview Table 57. Mirion Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Mirion Personal Dosimetry Service Product Portfolio Table 59. Mirion Recent Development Table 60. RadPro Company Information Table 61. RadPro Business Overview Table 62. RadPro Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. RadPro Personal Dosimetry Service Product Portfolio Table 64. RadPro Recent Development Table 65. Sanova Company Information Table 66. Sanova Business Overview Table 67. Sanova Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sanova Personal Dosimetry Service Product Portfolio Table 69. Sanova Recent Development Table 70. TÜV Rheinland Company Information Table 71. TÜV Rheinland Business Overview Table 72. TÜV Rheinland Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. TÜV Rheinland Personal Dosimetry Service Product Portfolio Table 74. TÜV Rheinland Recent Development Table 75. SCI Company Information Table 76. SCI Business Overview Table 77. SCI Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. SCI Personal Dosimetry Service Product Portfolio Table 79. SCI Recent Development Table 80. Centro de Dosimetría Company Information Table 81. Centro de Dosimetría Business Overview Table 82. Centro de Dosimetría Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Centro de Dosimetría Personal Dosimetry Service Product Portfolio Table 84. Centro de Dosimetría Recent Development Table 85. ARPANSA Company Information Table 86. ARPANSA Business Overview Table 87. ARPANSA Personal Dosimetry Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. ARPANSA Personal Dosimetry Service Product Portfolio Table 89. ARPANSA Recent Development Table 90. Sierra Radiation Company Information Table 91. Sierra Radiation Business Overview Table 92. Sierra Radiation Personal Dosimetry Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Sierra Radiation Personal Dosimetry Service Product Portfolio Table 94. Sierra Radiation Recent Development Table 95. IRS Company Information Table 96. IRS Business Overview Table 97. IRS Personal Dosimetry Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. IRS Personal Dosimetry Service Product Portfolio Table 99. IRS Recent Development Table 100. Dental Directory Company Information Table 101. Dental Directory Business Overview Table 102. Dental Directory Personal Dosimetry Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Dental Directory Personal Dosimetry Service Product Portfolio Table 104. Dental Directory Recent Development Table 105. North America Personal Dosimetry Service Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Personal Dosimetry Service Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Personal Dosimetry Service Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Personal Dosimetry Service Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Personal Dosimetry Service Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Personal Dosimetry Service Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Personal Dosimetry Service Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Personal Dosimetry Service Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Personal Dosimetry Service Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Personal Dosimetry Service Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Personal Dosimetry Service Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Personal Dosimetry Service Revenue by Country (US$ Million) & (2027-2032) Table 119. China Personal Dosimetry Service Revenue by Type (2021-2026) & (US$ Million) Table 120. China Personal Dosimetry Service Revenue by Type (2027-2032) & (US$ Million) Table 121. China Personal Dosimetry Service Revenue by Application (2021-2026) & (US$ Million) Table 122. China Personal Dosimetry Service Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Personal Dosimetry Service Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Personal Dosimetry Service Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Personal Dosimetry Service Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Personal Dosimetry Service Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Personal Dosimetry Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Personal Dosimetry Service Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Personal Dosimetry Service Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Personal Dosimetry Service Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Personal Dosimetry Service Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Personal Dosimetry Service Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Personal Dosimetry Service Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Personal Dosimetry Service Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Personal Dosimetry Service Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Personal Dosimetry Service Image Figure 2. Global Personal Dosimetry Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Personal Dosimetry Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Badge Dosimetry Image Figure 5. Thermoluminescent Dosimetry (TLD) Image Figure 6. Optically Stimulated Luminescence (OSL) Image Figure 7. Electronic Dosimeters Image Figure 8. Others Image Figure 9. Global Personal Dosimetry Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Personal Dosimetry Service Market Size Share 2021 VS 2025 VS 2032 Figure 11. Medical Image Figure 12. Industrial Image Figure 13. Research Image Figure 14. Nuclear Facilities Image Figure 15. Others Image Figure 16. Global Personal Dosimetry Service Market Size (US$ Million) & (2021-2032) Figure 17. Global Personal Dosimetry Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Personal Dosimetry Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Personal Dosimetry Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Personal Dosimetry Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Personal Dosimetry Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Personal Dosimetry Service Revenue Market Share by Type (2021-2032) Figure 24. Global Personal Dosimetry Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Personal Dosimetry Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Personal Dosimetry Service Revenue Market Share by Application (2021-2032) Figure 27. North America Personal Dosimetry Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Personal Dosimetry Service Revenue Share by Type (2021-2032) Figure 29. North America Personal Dosimetry Service Revenue Share by Application (2021-2032) Figure 30. North America Personal Dosimetry Service Revenue Share by Country (2021-2032) Figure 31. United States Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Personal Dosimetry Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Personal Dosimetry Service Revenue Share by Type (2021-2032) Figure 36. Europe Personal Dosimetry Service Revenue Share by Application (2021-2032) Figure 37. Europe Personal Dosimetry Service Revenue Share by Country (2021-2032) Figure 38. Germany Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Personal Dosimetry Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Personal Dosimetry Service Revenue Share by Type (2021-2032) Figure 48. China Personal Dosimetry Service Revenue Share by Application (2021-2032) Figure 49. Asia Personal Dosimetry Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Personal Dosimetry Service Revenue Share by Type (2021-2032) Figure 51. Asia Personal Dosimetry Service Revenue Share by Application (2021-2032) Figure 52. Asia Personal Dosimetry Service Revenue Share by Region (2021-2032) Figure 53. Japan Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Personal Dosimetry Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Personal Dosimetry Service Revenue Share by Type (2021-2032) Figure 61. SAMEA Personal Dosimetry Service Revenue Share by Application (2021-2032) Figure 62. SAMEA Personal Dosimetry Service Revenue Share by Country (2021-2032) Figure 63. Brazil Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Personal Dosimetry Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Badge Dosimetry
  • Thermoluminescent Dosimetry (TLD)
  • Optically Stimulated Luminescence (OSL)
  • Electronic Dosimeters
  • Others
Applications
  • Medical
  • Industrial
  • Research
  • Nuclear Facilities
  • Others
Companies covered
  • Landauer
  • Chiyoda Technol Corporation
  • Kinetics
  • Mirion
  • RadPro
  • Sanova
  • TÜV Rheinland
  • SCI
  • Centro de Dosimetría
  • ARPANSA
  • Sierra Radiation
  • IRS
  • Dental Directory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Personal Dosimetry Service Market by Type
  3. 1.2.1 Global Personal Dosimetry Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Badge Dosimetry
  5. 1.2.3 Thermoluminescent Dosimetry (TLD)
  6. 1.2.4 Optically Stimulated Luminescence (OSL)
  7. 1.2.5 Electronic Dosimeters
  8. 1.2.6 Others
  9. 1.3 Personal Dosimetry Service Market by Application
  10. 1.3.1 Global Personal Dosimetry Service Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Medical
  12. 1.3.3 Industrial
  13. 1.3.4 Research
  14. 1.3.5 Nuclear Facilities
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Personal Dosimetry Service Market Dynamics
  1. 2.1 Personal Dosimetry Service Industry Trends
  2. 2.2 Personal Dosimetry Service Industry Drivers
  3. 2.3 Personal Dosimetry Service Industry Opportunities and Challenges
  4. 2.4 Personal Dosimetry Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Personal Dosimetry Service Market Perspective (2021-2032)
  2. 3.2 Global Personal Dosimetry Service Growth Trends by Region
  3. 3.2.1 Global Personal Dosimetry Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Personal Dosimetry Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Personal Dosimetry Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Personal Dosimetry Service Revenue by Players
  2. 4.1.1 Global Personal Dosimetry Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Personal Dosimetry Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Personal Dosimetry Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Personal Dosimetry Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Personal Dosimetry Service Key Players Headquarters & Area Served
  7. 4.4 Global Personal Dosimetry Service Players, Product Type & Application
  8. 4.5 Global Personal Dosimetry Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Personal Dosimetry Service Market CR5 and HHI
  11. 4.6.3 2025 Personal Dosimetry Service Tier 1, Tier 2, and Tier 3
5 Personal Dosimetry Service Market Size by Type
  1. 5.1 Global Personal Dosimetry Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Personal Dosimetry Service Revenue by Type (2021-2032)
  3. 5.3 Global Personal Dosimetry Service Revenue Market Share by Type (2021-2032)
6 Personal Dosimetry Service Market Size by Application
  1. 6.1 Global Personal Dosimetry Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Personal Dosimetry Service Revenue by Application (2021-2032)
  3. 6.3 Global Personal Dosimetry Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Landauer
  2. 7.1.1 Landauer Company Information
  3. 7.1.2 Landauer Business Overview
  4. 7.1.3 Landauer Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Landauer Personal Dosimetry Service Product Portfolio
  6. 7.1.5 Landauer Recent Developments
  7. 7.2 Chiyoda Technol Corporation
  8. 7.2.1 Chiyoda Technol Corporation Company Information
  9. 7.2.2 Chiyoda Technol Corporation Business Overview
  10. 7.2.3 Chiyoda Technol Corporation Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Chiyoda Technol Corporation Personal Dosimetry Service Product Portfolio
  12. 7.2.5 Chiyoda Technol Corporation Recent Developments
  13. 7.3 Kinetics
  14. 7.3.1 Kinetics Company Information
  15. 7.3.2 Kinetics Business Overview
  16. 7.3.3 Kinetics Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Kinetics Personal Dosimetry Service Product Portfolio
  18. 7.3.5 Kinetics Recent Developments
  19. 7.4 Mirion
  20. 7.4.1 Mirion Company Information
  21. 7.4.2 Mirion Business Overview
  22. 7.4.3 Mirion Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Mirion Personal Dosimetry Service Product Portfolio
  24. 7.4.5 Mirion Recent Developments
  25. 7.5 RadPro
  26. 7.5.1 RadPro Company Information
  27. 7.5.2 RadPro Business Overview
  28. 7.5.3 RadPro Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 RadPro Personal Dosimetry Service Product Portfolio
  30. 7.5.5 RadPro Recent Developments
  31. 7.6 Sanova
  32. 7.6.1 Sanova Company Information
  33. 7.6.2 Sanova Business Overview
  34. 7.6.3 Sanova Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sanova Personal Dosimetry Service Product Portfolio
  36. 7.6.5 Sanova Recent Developments
  37. 7.7 TÜV Rheinland
  38. 7.7.1 TÜV Rheinland Company Information
  39. 7.7.2 TÜV Rheinland Business Overview
  40. 7.7.3 TÜV Rheinland Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 TÜV Rheinland Personal Dosimetry Service Product Portfolio
  42. 7.7.5 TÜV Rheinland Recent Developments
  43. 7.8 SCI
  44. 7.8.1 SCI Company Information
  45. 7.8.2 SCI Business Overview
  46. 7.8.3 SCI Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 SCI Personal Dosimetry Service Product Portfolio
  48. 7.8.5 SCI Recent Developments
  49. 7.9 Centro de Dosimetría
  50. 7.9.1 Centro de Dosimetría Company Information
  51. 7.9.2 Centro de Dosimetría Business Overview
  52. 7.9.3 Centro de Dosimetría Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Centro de Dosimetría Personal Dosimetry Service Product Portfolio
  54. 7.9.5 Centro de Dosimetría Recent Developments
  55. 7.10 ARPANSA
  56. 7.10.1 ARPANSA Company Information
  57. 7.10.2 ARPANSA Business Overview
  58. 7.10.3 ARPANSA Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 ARPANSA Personal Dosimetry Service Product Portfolio
  60. 7.10.5 ARPANSA Recent Developments
  61. 7.11 Sierra Radiation
  62. 7.11.1 Sierra Radiation Company Information
  63. 7.11.2 Sierra Radiation Business Overview
  64. 7.11.3 Sierra Radiation Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sierra Radiation Personal Dosimetry Service Product Portfolio
  66. 7.11.5 Sierra Radiation Recent Developments
  67. 7.12 IRS
  68. 7.12.1 IRS Company Information
  69. 7.12.2 IRS Business Overview
  70. 7.12.3 IRS Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 IRS Personal Dosimetry Service Product Portfolio
  72. 7.12.5 IRS Recent Developments
  73. 7.13 Dental Directory
  74. 7.13.1 Dental Directory Company Information
  75. 7.13.2 Dental Directory Business Overview
  76. 7.13.3 Dental Directory Personal Dosimetry Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Dental Directory Personal Dosimetry Service Product Portfolio
  78. 7.13.5 Dental Directory Recent Developments
8 North America
  1. 8.1 North America Personal Dosimetry Service Revenue (2021-2032)
  2. 8.2 North America Personal Dosimetry Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Personal Dosimetry Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Personal Dosimetry Service Revenue by Type (2027-2032)
  5. 8.3 North America Personal Dosimetry Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Personal Dosimetry Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Personal Dosimetry Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Personal Dosimetry Service Revenue by Application (2027-2032)
  9. 8.5 North America Personal Dosimetry Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Personal Dosimetry Service Revenue by Country
  11. 8.6.1 North America Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Personal Dosimetry Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Personal Dosimetry Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Personal Dosimetry Service Revenue (2021-2032)
  2. 9.2 Europe Personal Dosimetry Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Personal Dosimetry Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Personal Dosimetry Service Revenue by Type (2027-2032)
  5. 9.3 Europe Personal Dosimetry Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Personal Dosimetry Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Personal Dosimetry Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Personal Dosimetry Service Revenue by Application (2027-2032)
  9. 9.5 Europe Personal Dosimetry Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Personal Dosimetry Service Revenue by Country
  11. 9.6.1 Europe Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Personal Dosimetry Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Personal Dosimetry Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Personal Dosimetry Service Revenue (2021-2032)
  2. 10.2 China Personal Dosimetry Service Revenue by Type (2021-2032)
  3. 10.2.1 China Personal Dosimetry Service Revenue by Type (2021-2026)
  4. 10.2.2 China Personal Dosimetry Service Revenue by Type (2027-2032)
  5. 10.3 China Personal Dosimetry Service Revenue Share by Type (2021-2032)
  6. 10.4 China Personal Dosimetry Service Revenue by Application (2021-2032)
  7. 10.4.1 China Personal Dosimetry Service Revenue by Application (2021-2026)
  8. 10.4.2 China Personal Dosimetry Service Revenue by Application (2027-2032)
  9. 10.5 China Personal Dosimetry Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Personal Dosimetry Service Revenue (2021-2032)
  2. 11.2 Asia Personal Dosimetry Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Personal Dosimetry Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Personal Dosimetry Service Revenue by Type (2027-2032)
  5. 11.3 Asia Personal Dosimetry Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Personal Dosimetry Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Personal Dosimetry Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Personal Dosimetry Service Revenue by Application (2027-2032)
  9. 11.5 Asia Personal Dosimetry Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Personal Dosimetry Service Revenue by Country
  11. 11.6.1 Asia Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Personal Dosimetry Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Personal Dosimetry Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Personal Dosimetry Service Revenue (2021-2032)
  2. 12.2 SAMEA Personal Dosimetry Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Personal Dosimetry Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Personal Dosimetry Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Personal Dosimetry Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Personal Dosimetry Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Personal Dosimetry Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Personal Dosimetry Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Personal Dosimetry Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Personal Dosimetry Service Revenue by Country
  11. 12.6.1 SAMEA Personal Dosimetry Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Personal Dosimetry Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Personal Dosimetry Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.